Zota Health Care Ltd

Zota Health Care Ltd., a Surat-based pharmaceutical manufacturer specialising in pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products, reported deeply concerning Q3 FY26 results that have intensified investor anxieties about the company's aggressive expansion strategy. The company posted a consolidated net loss of ₹29.50 crores for the quarter ended December 2025, marking an alarming 84.95% sequential deterioration from the previous quarter's loss of ₹15.95 crores and a 57.92% year-on-year widening from the ₹18.68 crores loss in Q3 FY25.

Zota Health Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Zota Health Care Ltd is rated 'Sell' by MarketsMOJO, a rating that was last updated on 05 May 2025. While the rating change occurred several months ago, the analysis and financial metrics discussed here reflect the stock's current position as of 21 January 2026, providing investors with an up-to-date perspective on the company’s standing.

Zota Health Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Zota Health Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 December 2025, providing investors with an up-to-date view of the company’s performance and outlook.

Zota Health Care, a small-cap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting nuanced changes across key analytical parameters. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trends, and technical outlook amid a volatile market backdrop.

Zota Health Care has experienced a notable shift in its technical momentum, reflecting a nuanced market assessment as various indicators present a blend of bullish and bearish signals. The stock’s recent price movements and technical parameters suggest evolving investor sentiment within the Pharmaceuticals & Biotechnology sector.

Zota Health Care has experienced a revision in its market evaluation, reflecting changes in its fundamental and technical outlook. This shift comes amid a complex backdrop of financial stability, valuation concerns, and recent stock performance within the Pharmaceuticals & Biotechnology sector.

Zota Health Care has reached a significant milestone by hitting an all-time high in its stock price, reflecting a remarkable trajectory in the Pharmaceuticals & Biotechnology sector. This achievement underscores the company’s sustained market presence and robust performance over multiple time frames.

Zota Health Care has reached a significant milestone by touching an all-time high of Rs.1712.7, marking a remarkable achievement in its market journey within the Pharmaceuticals & Biotechnology sector.

Zota Health Care has reached a significant milestone by hitting an all-time high of Rs.1640 today, marking a notable event in the Pharmaceuticals & Biotechnology sector. This achievement reflects the company’s sustained performance across multiple time frames and its ability to outperform key market benchmarks.

Zota Health Care reported flat financial performance for the quarter ending September 2025, despite achieving record net sales of Rs 128.95 crore and a strong operating profit to interest ratio. However, challenges include a decline in profit before tax and a low debtors turnover ratio, alongside rising interest expenses.

Zota Health Care's stock reached an all-time high of Rs. 1633 on November 17, 2025, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has consistently outperformed its sector and demonstrated impressive growth over various time frames, solidifying its market position.

Zota Health Care, a small-cap company in the Pharmaceuticals and Biotechnology sector, has experienced significant price fluctuations and strong performance, outperforming the Sensex over various time frames. Technical indicators show a mix of bullish and bearish signals, reflecting the stock's volatility and positive market dynamics.